US FDA approves Pfizer's blood cancer therapy
Go back to US FDA approves Pfizer's blood cancer therapy| Pfizer Inc. (NYSE: PFE) | Delayed: 27.80 -0.32 (1.14%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.12 | 52 Week High | $37.39 | |||
| Open | $28.15 | 52 Week Low | $28.25 | |||
| Day High | $28.16 | P/E | 16.85 | |||
| Day Low | $27.44 | EPS | $1.65 | |||
| Volume | 35,007,163 | |||||
